Chemotherapy and Drug Information

Vulnerability to Infection Increases for Breast Cancer Survivors Treated With Chemotherapy

Chemotherapy for breast cancer can affect the body's ability to ward off common illnesses.

First-line Afatinib Benefits Lung Cancer Patients With Brain Metastases

For patients with non-small cell lung cancer who have EGFR mutations and brain metastases, progression-free survival was improved with afatinib compared to chemotherapy.

Nab-paclitaxel Increases Complete Response Rate in Invasive Breast Cancer

Replacing paclitaxel with nab-paclitaxel, followed by neoadjuvant epirubicin and cyclophosphamide, proved beneficial for patients with invasive breast cancer.

Data Analysis Shows 8-week Chemoradiotherapy-to-Surgery Timeline Achieves Optimal Tumor Response

Overall survival was best and resection of residual locally advanced rectal tumors most successful when surgery occurred at precisely 8 weeks, or 56 days, after completion of chemoradiotherapy.

CDX2 Expression Predictive of Chemotherapy Benefit in Patients With Stage II Colorectal Cancer

Lack of CDX2 expression identified a subgroup of patients with high-risk stage II colon cancer who seemed to benefit from adjuvant chemotherapy.

Development of Microtubulin Inhibitor Is a Potential Lead to Novel Biologic Therapy

Gatastatin, an inhibitor specific for γ-tubulin, known to be overexpressed in some cancer cells, has been identified and holds potential for the development of anticancer agents.

Fosaprepiant May Not Provide Same Benefit as Aprepitant With 5-day Cisplatin

Fosaprepiant May Not Provide Same Benefit as Aprepitant With 5-day Cisplatin

Fosaprepitant may have a lower complete response rate than aprepitant when used in combination with a 5HT3 receptor antagonist.

Reduced Toxicity, Similar Efficacy Achieved With Novel Regimen for Advanced Rectal Cancer

No difference in local efficacy was found between two treatment regimens for colorectal cancer: short-course (5-day) radiation followed by consolidation chemotherapy before surgery and standard 5-week chemoradiation.

Understanding Drug Naming Nomenclature

Understanding Drug Naming Nomenclature

Why do the antibody drugs have such long names?

Adjuvant Therapy Increases Survival in Small-Cell Lung Cancer

Adjuvant Therapy Increases Survival in Small-Cell Lung Cancer

Chemotherapy, with or without cranial irradiation, has been associated with improved survival versus surgery alone for patients with early-stage small-cell lung cancer (SCLC) undergoing resection.

Stat Consult Slideshows

Fluorouracil (5-FU)

This slideshow reviews fluorouracil (5-FU), indicated for palliative treatment of breast cancer, colorectal cancer, gastric cancer, and carcinoma of the pancreas; also adjuvant treatment of colorectal cancer.

Netupitant/Palonosetron (Akynzeo)

This slideshow reviews netupitant/palonosetron (Akynzeo), indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy.

Bevacizumab (Avastin) - cervical cancer

This slideshow reviews bevacizumab (Avastin), indicated for cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan in persistent, recurrent, or metastatic disease.

To view all content in our Stat Consult section, please click here.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs